Implied Macular Degeneration, BPH Claims Subject Of “Courtesy” Letters
This article was originally published in The Tan Sheet
Claims for Rexall's Vuemax Intensive suggest the eye-health supplement is intended to "treat, prevent or mitigate" macular degeneration, a July 30 FDA "courtesy" letter to the firm states
You may also be interested in...
Five herbal ingredients in Pregnancy-6 pose potentially dangerous risks to pregnant women, FDA's Center for Food Safety & Applied Nutrition tells Nature's Way in a recent warning letter.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning